Egis World

Our products reach more than 100 countries

Click here to learn more

Pharmaceutical Company

Our activities incorporate all areas in the pharmaceutical value chain

Click here to learn more

Research & Development

One of the fundamental pillars of our strategy is innovation.

Click here to learn more
Own subsidiaries / Representative offices
Sales through Partners
Innovation

Egis Invests Over HUF 14 Billion in Körmend Site Development

As part of its ongoing development program, Egis Pharmaceuticals PLC is investing over HUF 14 billion to expand its Körmend site. The project, supported by HUF 3.5 billion in government funding, will increase production capacities and modernise technological infrastructure, further strengthening the strategic importance of the facility.

More
Egis World

Egis Commits to Voluntary Price Cap

As a key player in the Hungarian pharmaceutical industry, Egis is voluntarily joining the initiative of the Ministry of National Economy aimed at curbing the price increases of Reparon Ointment 30g.

More
Egis World

Volunteer Day at Two Locations

Our colleagues participated in a dedicated, organized volunteer day.

More
More articles

Egis World

Egis’ products reach more than 100 countries around the world.

Egis’ products reach more than 100 countries.  Our main focus lies on treating diseases of the cardiovascular and central nervous systems.

Learn more

A place to work

Join us!

Healthcare Professionals

and prescription drugs

Professional content for visitors with qualification in medicine or pharmaceuticals This content is only accessible by using your personal password.

Learn more
Therapeutic areas
Therapeutic areas
Cardiovascular system
Central nervous system
Gastroenterology
Oncology
Women´s health
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox